DelveInsight's Emphysema Market Insights report includes a comprehensive understanding of current treatment practices, ...

Respiratory diseases such as Asthma and Chronic Obstructive Pulmonary Disease (COPD) are on the rise partly because of ...

A live and archived webcast of the event will be available on the “Investors” section of the Pulmonx website at About Pulmonx Corporation Pulmonx Corporation (Nasdaq: LUNG) is a global leader in ...

Temple Lung Center says artificial intelligence software makes the already good imaging of chest CT scans even better.

Lung cancer remains the leading cause of cancer-related death in the United States. The good news is that early detection ...

Your diet significantly impacts lung health, influencing inflammation and breathing. Avoiding processed meats, salty foods, ...

Learn how accelerating drug discovery is reshaping the pathway from lab findings to effective therapies with real-world data.

Patients with IPF and emphysema who received antifibrotic agents had similar outcomes to patients with IPF alone.

Ensifentrine significantly improved lung function after 12 weeks in patients with moderate to severe COPD with and without ...

After 1 year of biologic therapy, admissions requiring noninvasive ventilation among patients with COPD and type 2 ...

Among adults with COPD and type 2 inflammation, having a history of cardiovascular or metabolic disease did not change ...

Inhaled corticosteroids pose long-term risks in COPD management, prompting careful screening and potential de-escalation ...